Publication	Data		Fish	Anatomy
Das et al., 2022	Fig. 3		flt4um203/um203; nz101Tg/nz101Tg; s843Tg/s843Tg ,   flt4um203/um203	anal fin nucleate erythrocyte accumulation fin vasculature, abnormal anal fin radial decreased object quality, abnormal lymph vasculature DsRed expression decreased amount, abnormal
Fontana et al., 2020	Fig. 2		flt4hu4602/hu4602	atrioventricular valve development disrupted, abnormal heart klf2a expression decreased amount, abnormal heart notch1b expression increased amount, abnormal
	Fig. 4		flt4hu4602/hu4602	heart klf2a expression decreased amount, abnormal heart notch1b expression increased amount, abnormal
Gancz et al., 2019	Figure 2		flt4um203/um203; nz101Tg	bulbus arteriosus lacks parts or has fewer parts of type bulbus arteriosus lymph vessel, abnormal bulbus arteriosus lymphangiogenic sprout decreased amount, abnormal
	Figure 2 supplement 2.		flt4um203/um203; nz101Tg	medial facial lymph vessel decreased length, abnormal
	Figure 3		flt4um203/um203; nz101Tg; y1Tg	cardiac ventricle lymph vessel absent, abnormal cardiac ventricle lymph vessel agenesis, abnormal
	Figure 4		flt4um203/um203; nz101Tg; y1Tg	cardiac ventricle lacks all parts of type cardiac lymphatic endothelial cluster, abnormal
Vogrin et al., 2019	Fig. 4		flt4hu4602/+; nz101Tg; y7Tg ,   flt4hu4602/hu4602; nz101Tg; y7Tg	thoracic duct absent, abnormal thoracic duct has fewer parts of type endothelial cell, abnormal
	Fig. 5		flt4hu4602/+; nz101Tg; y7Tg ,   flt4hu4602/hu4602; nz101Tg; y7Tg	lateral facial lymph vessel absent, abnormal lateral facial lymph vessel has fewer parts of type endothelial cell, abnormal medial facial lymph vessel absent, abnormal medial facial lymph vessel has fewer parts of type endothelial cell, abnormal otolithic lymph vessel absent, abnormal otolithic lymph vessel has fewer parts of type endothelial cell, abnormal
Bower et al., 2017	Fig. S7		nz101Tg; s843Tg + MO3-flt4	midbrain lymph vessel lacks all parts of type endothelial cell, abnormal
Shin et al., 2016	Fig. 1		flt4um131/um131	endothelial cell flt4 expression decreased amount, abnormal posterior cardinal vein flt4 expression decreased amount, abnormal
	Fig. 2		flt4um200/um200; y1Tg ,   flt4um131/um131; y1Tg ,   flt4um131/+; y1Tg ,   flt4um200/+; y1Tg	primordial hindbrain channel absent, abnormal primordial hindbrain channel malformed, abnormal primordial hindbrain channel vasculature development decreased occurrence, abnormal thoracic duct absent, abnormal thoracic duct lymph vessel development decreased occurrence, abnormal thoracic duct lymph vessel development process quality, abnormal thoracic duct malformed, abnormal
	Fig. 3		flt4um200/um200 ,   flt4um200/um200; y1Tg ,   flt4um131/um131; y1Tg ,   flt4um131/um131 ,   flt4um159/um159 ,   flt4um200/+; y1Tg ,   flt4um159/+	intersegmental artery increased amount, abnormal intersegmental vein decreased amount, abnormal intersegmental vein EGFP expression absent, abnormal lymphangiogenic sprout decreased amount, abnormal parachordal vessel absent, abnormal parachordal vessel vasculature development decreased occurrence, abnormal posterior cardinal vein vascular sprouts Ab2-tek labeling absent, abnormal posterior caudal vein vascular sprouts decreased amount, abnormal
	Fig. 4		flt4um200/um200; y1Tg	posterior cardinal vein endothelial cell ab9-mapk labeling absent, abnormal posterior cardinal vein vascular sprouts ab9-mapk labeling absent, abnormal
	Fig. 6		flt4um131/um131	digestive system anatomical region edematous, abnormal eye anatomical region edematous, abnormal heart anatomical region edematous, abnormal swim bladder inflation decreased occurrence, abnormal
	Fig. 7		flt4um131/um131; y1Tg ,   flt4um200/um200; nz101Tg ,   flt4um131/um131; nz101Tg	lateral facial lymph vessel closed, abnormal lateral facial lymph vessel lymph vessel development process quality, abnormal lateral facial lymph vessel lymphangiogenic sprout absent, abnormal lateral facial lymph vessel lymphangiogenic sprout DsRed expression absent, abnormal lateral facial lymph vessel malformed, abnormal lateral facial lymph vessel truncated, abnormal otolithic lymph vessel absent, abnormal otolithic lymph vessel DsRed expression absent, abnormal otolithic lymph vessel lymph vessel development delayed, abnormal
Kok et al., 2015	Fig. 1		flt4um203/um203; y1Tg ,   flt4um203/um203	anatomical structure flt4 expression decreased distribution, abnormal lymph vessel development disrupted, abnormal primordial hindbrain channel absent, abnormal thoracic duct absent, abnormal vascular lymphangioblast absent, abnormal
Astin et al., 2014	Fig. 1		flt4hu4602/hu4602; nz150Tg ,   nz150Tg + MO3-flt4	facial lymphatic vessel lateral region decreased length, abnormal thoracic duct aplastic, abnormal thoracic duct lymphangiogenesis decreased process quality, abnormal
	Fig. 2		nz150Tg + MO3-flt4	facial lymphatic vessel lymphangiogenesis decreased process quality, abnormal facial lymphatic vessel lymphangiogenic sprout aplastic, abnormal thoracic duct lymphangiogenesis decreased process quality, abnormal
	Fig. S2		nz150Tg + MO3-flt4	posterior cardinal vein lacks parts or has fewer parts of type lymphangiogenic sprout, abnormal
	Fig. S5		nz101Tg; s843Tg + MO3-flt4	intestine lymphangiogenesis decreased process quality, abnormal
Lai et al., 2014	Fig. 3		WT + MO3-flt4	angiogenesis process quality, abnormal intersegmental vein decreased length, abnormal intersegmental vessel angiogenesis process quality, abnormal
	Fig. 8		y1Tg + MO3-flt4	intersegmental vein decreased length, abnormal intersegmental vessel angiogenesis process quality, abnormal
Le Guen et al., 2014	Fig. 2		flt4hu4602/hu4602; s896Tg; y1Tg	thoracic duct absent, abnormal
	Fig. 4		y1Tg + MO3-flt4	MAPK cascade disrupted, abnormal
	Fig. 6		y1Tg + MO3-flt4	lymphangioblast cord absent, abnormal venous endothelial cell migration involved in lymph vessel development disrupted, abnormal
Huang et al., 2013	Fig. 7		y1Tg + MO3-flt4	lymph vessel morphogenesis disrupted, abnormal thoracic duct hypoplastic, abnormal
Kwon et al., 2013	Fig. 6		ml2Tg; ncv1Tg + MO1-flt4	motor neuron axon guidance process quality, abnormal
Gore et al., 2011	Fig. 7		y1Tg/y1Tg + MO1-flt4	angiogenesis disrupted, abnormal intersegmental vessel absent, abnormal
Hermans et al., 2010	Fig. 6		y1Tg + MO3-flt4	posterior cardinal vein vascular sprouts absent, abnormal posterior cardinal vein vascular sprouts decreased amount, abnormal thoracic duct absent, abnormal thoracic duct decreased length, abnormal
Herbert et al., 2009	Fig. 3		WT + MO1-flt4	selective angioblast sprouting disrupted, abnormal venous blood vessel morphogenesis disrupted, abnormal
Hogan et al., 2009	Fig. 1		flt4hu4602/hu4602; y1Tg	lymph vessel development disrupted, abnormal thoracic duct aplastic, abnormal
	Fig. 3		y1Tg + MO3-flt4	blood vessel development disrupted, abnormal lymph vessel development disrupted, abnormal primordial hindbrain channel aplastic, abnormal thoracic duct aplastic, abnormal
Siekmann et al., 2007	Fig. 3		y7Tg + MO1-flt4	intersegmental artery blood vessel endothelial cell decreased amount, abnormal
	Fig. S5		y7Tg + MO1-flt4	intersegmental vessel blood vessel endothelial cell decreased amount, abnormal